Bergamot essential oil (BEO) aromatherapy has not been researched as a cancer treatment. It has been investigated as an adjunct to stem cell therapy in children as a possible mitigator for pain, anxiety, and nausea and was found to be worse than no treatment.[1]
While several individual constituents of BEO have been researched as cancer treatments — for example, bergapten and bergamottin, phototoxic furocoumarins present in small quantities in BEO and in other citrus fruits, have been researched in vitro[2][3] — there is no evidence supporting the use of BEO as a cancer treatment.
References
- ^Ndao DH, Ladas EJ, Cheng B, Sands SA, Snyder KT, Garvin JH Jr, Kelly KMInhalation aromatherapy in children and adolescents undergoing stem cell infusion: results of a placebo-controlled double-blind trial.Psychooncology.(2012 Mar)
- ^Li J, Hussain SA, Daddam JR, Sun MBergapten attenuates human papillary thyroid cancer cell proliferation by triggering apoptosis and the GSK-3β, P13K and AKT pathways.Adv Clin Exp Med.(2024 Apr 9)
- ^Ko JH, Arfuso F, Sethi G, Ahn KSPharmacological Utilization of Bergamottin, Derived from Grapefruits, in Cancer Prevention and Therapy.Int J Mol Sci.(2018 Dec 14)